Last update:

Oncology & Cancer news

Oncology & Cancer

AI uncovers how DNA architecture failures trigger blood cancer

Cancer isn't just about broken genes—it's about broken architecture. Imagine a city where roads suddenly vanish, cutting off neighborhoods from essential services. That's what happens inside cells when the 3D structure ...

Oncology & Cancer

Antibody therapy eradicates traces of multiple myeloma in preliminary trial

Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted by researchers at Sylvester ...

Oncology & Cancer

Antibody halts triple-negative breast cancer in preclinical models

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other breast cancers treatable with ...

Oncology & Cancer

Backup DNA repair system could be cancer's weak spot

The DNA inside our cells is constantly being damaged, and one of the worst kinds of damage is a double-strand break—when both sides of the DNA helix are cut at once. Healthy cells can normally fix these breaks using highly ...

Oncology & Cancer

Simple urine test developed to screen bladder cancer

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose and stage bladder cancer, offering a much-needed alternative to invasive ...

Oncology & Cancer

Update made to cervical cancer screening guideline

The American Cancer Society (ACS) released updated guidelines today for cervical cancer screening, reflecting advances in disease detection and accessibility in the United States. The updated guideline for women at average ...

Oncology & Cancer

Biomarkers link ER+ breast cancer to neighborhood poverty

Scientists have long known that Black women with estrogen-receptor positive breast cancer and those who live in disadvantaged neighborhoods often have more aggressive forms of the disease and poorer survival rates. However, ...

Oncology & Cancer

Two-drug combination could improve colorectal cancer therapy

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown—only a few risk factors are known—and it is ...

Oncology & Cancer

Zenocutuzumab shows clinical benefit in rare bile duct cancer

Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led to responses in more than a third of patients with neuregulin 1 (NRG1)-positive cholangiocarcinoma, ...

Oncology & Cancer

How to lower your risk of breast cancer

About 1 in 8 women in the U.S. will have breast cancer in their lifetime, making it the most common cancer among women. So you might wonder: Is there anything you can do to prevent it?

Oncology & Cancer

How is radiation therapy portrayed in art?

Because patient perceptions of radiation can influence their willingness to receive it as treatment, researchers recently examined how radiation therapy is represented in different forms of art.

Oncology & Cancer

Preventing malnutrition in people with blood cancer

Malnutrition is a common but difficult-to-manage complication for people with cancer, especially those treated with intensive chemotherapy. Now, new research from the University of Adelaide has delivered new insights into ...

Oncology & Cancer

Disrupting cancer's secret hubs: A new way to halt tumor growth

In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form—but instead of fueling progress, they supercharge disease. That's what researchers at the Texas A&M University Health Science ...